| Literature DB >> 12914878 |
Mauricio G Cohen1, Enrique Tuero, Jorge Bluguermann, Rubén Kevorkian, Daniel H Berrocal, Oscar Carlevaro, Eduardo Picabea, Michael P Hudson, Robert J Siegel, Lori Douthat, Adam B Greenbaum, Debra Echt, W Douglas Weaver, Liliana R Grinfeld.
Abstract
In preclinical experiments, the combination of transcutaneous, low-frequency ultrasound and thrombolytic therapy has shown improved patency rates over thrombolytics alone. A total of 25 patients with myocardial infarction were treated with a thrombolytic agent and adjunctive transcutaneous ultrasound. No unanticipated major adverse events were observed.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12914878 DOI: 10.1016/s0002-9149(03)00666-0
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778